Skip to content
The GLP-1 Verdict
Menu
Ranked #203 · Grade C

Belle Health review

Nine-year-old Utah telehealth firm offering compounded and brand GLP-1s in all fifty states, carrying an unresolved February 2026 FDA warning letter.

Visit Belle Health Assume we may earn a commission, at no cost to you. It never changes The Verdict Score, nor a word of this review.
Semaglutide
From $119/mo (compounded)
Tirzepatide
From $175/mo (compounded)
Coverage
All 50 states
Brand-name
Yes

The scorecard

Belle Health scored on our six published factors. See the methodology.

Real-world results65/100
Price honesty60/100
Prescriber access75/100
Formulary choice85/100
Cancellation fairness50/100
Member support70/100

What we like

  • Offers brand Wegovy (from $1,400/mo) and brand Zepbound (from $1,999/mo) alongside the compounded lines, so a switch to an FDA-approved product does not mean changing provider
  • Compounded prices are published before intake: from $119 a month for semaglutide and from $175 a month for tirzepatide
  • Weekly registered-dietitian sessions are included in the monthly price at no extra charge
  • Trading since 2017, which is unusually long for this segment
  • The site states plainly that 'Compounded medications are not evaluated or approved by the FDA' rather than burying the caveat

The caveats

  • FDA Warning Letter 721795, dated 20 February 2026, to Belle Health LLC dba Belle over its website's compounded semaglutide and tirzepatide claims under FDCA sections 502(a) and 502(bb); no closeout letter has been published
  • Compounded semaglutide and tirzepatide are not FDA-approved and are not reviewed by the FDA for safety, effectiveness or quality
  • Both compounded prices are 'from' prices, so the figure you are quoted after intake may be higher than the one advertised
  • The pharmacy partners named in the Terms have been swapped out entirely, and two of the current four have publicly stepped back from GLP-1 compounding
  • No refunds on prescription or compounded products once shipped, and no telephone support is published

The verdict

Best for: Someone who wants a compounded starting price at the low end of the market with the option to switch to brand Wegovy or Zepbound on the same account. Nine-year-old Utah telehealth firm offering compounded and brand GLP-1s in all fifty states, carrying an unresolved February 2026 FDA warning letter.

Ranked #203 of 499 providers we have reviewed — for comparison, read the CoreAge Rx review, our #1 pick. On the board it sits between Willow, 68/100 above and ARSYNL Rx at 67/100 below, with the BloomWell Rx ruling the next one down.

If that ruling leaves you undecided, the 7 programmes we rank against Belle Health are graded on the same six factors and listed in score order. We have also ruled on it directly: CoreAge Rx vs Belle Health goes to CoreAge Rx, 94/100 to 67/100.

Visit Belle Health

Compare with other providers

All 498 other providers we've reviewed, in our overall ranking order.

Every other program we track (492)

Pricing, states and verification reflect Belle Health's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on Belle Health's site. Not medical advice; see our disclosure.

← Back to all rankings